| |
| |
|
| Insider
Information: |
Fitzpatrick Mark J. |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
34,112 |
|
|
Indirect Shares
|
100 |
|
|
| Direct
Value |
$73,741 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
34,212 |
|
|
| Total
Value |
$73,741 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aegerion Pharmaceuticals, Inc. |
AEGR |
Chief Financial Officer |
2014-08-19 |
9,500 |
2013-11-18 |
100 |
Premium* |
|
|
Chiasma, Inc |
CHMA |
President |
2020-12-04 |
19,612 |
2018-12-20 |
0 |
Premium* |
|
|
Allena Pharmaceuticals, Inc. |
ALNA |
Director |
2021-04-06 |
5,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNA |
Allena Pharmaceuticals, I... |
Director |
– • – |
2021-04-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
% |
|
| CHMA |
Chiasma, Inc |
President |
• – – |
2020-12-04 |
4 |
OE |
$2.60 |
$26,000 |
D/D |
10,000 |
19,612 |
0 |
- |
|
| CHMA |
Chiasma, Inc |
President and CEO |
• • – |
2018-12-20 |
4 |
AB |
$2.50 |
$24,030 |
D/D |
9,612 |
9,612 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2014-08-19 |
4 |
B |
$30.64 |
$35,236 |
D/D |
1,150 |
9,500 |
2.74 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2014-03-04 |
4 |
OE |
$17.64 |
$44,100 |
D/D |
2,500 |
8,350 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2014-02-10 |
4 |
OE |
$17.64 |
$132,300 |
D/D |
7,500 |
13,350 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2014-02-10 |
4 |
AS |
$61.71 |
$469,544 |
D/D |
(7,500) |
5,850 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2013-11-18 |
5 |
GA |
$0.00 |
$0 |
I/I |
100 |
100 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2013-11-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
100 |
5,750 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2013-11-11 |
4 |
OE |
$17.64 |
$182,574 |
D/D |
10,350 |
5,850 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2013-11-11 |
4 |
AS |
$73.01 |
$592,829 |
D/D |
(7,500) |
3,000 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2013-08-14 |
4 |
AS |
$92.74 |
$700,816 |
D/D |
(7,500) |
500 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2013-08-14 |
4 |
OE |
$17.64 |
$132,300 |
D/D |
7,500 |
8,000 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2012-03-23 |
4 |
B |
$14.15 |
$7,076 |
D/D |
500 |
500 |
2.74 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
